Free Trial

Summer Street's Rating of Human Genome Sciences on 7/17/2012

On July 17, 2012, Summer Street updated its outlook on Human Genome Sciences (NASDAQ:HGSI) with the action "Downgrade", setting a "Neutral" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.